Main Article Content
The present study aims to evaluate the beneficiary effect of Nigella sativa in radiotherapy or chemotherapy. Cancer is one of the biggest threats of modern life, which is accepted as the second cause of death after myocardial infarction. Current chemotherapy, radiotherapy, surgery, etc. cannot provide complete treatment for cancer cases that cannot be diagnosed early. Nigella sativa has been used in the treatment of various diseases in traditional medicine for over 2000 years, since it is a natural medicinal medicine as well as a spice in the kitchen. The inadequacy of existing treatments encourages scientists to find alternative and more effective treatment methods. Many studies have important effects such as antibacterial, antifungal, antihelmintic, antioxidant, antidiabetic, antiinflammatory, analgesic, gastroprotective, hepatoprotective, renoprotective, anti-convulsant, antiastmia. As a result, Nigella sativa is used in in-vivo and in-vitro studies in cancer treatment by utilizing its beneficial and protective effects on many systems and it is known that it does not harm healthy cells. Although scientific studies are conducted, the current number of studies is limited. There is a need for clinical studies to show a possible positive effect on the current types of cancer.
Most read articles by the same author(s)
- Yasemin Benderli Cihan, Baki Taştan, Radiotherapy after D2 Lymph Node Dissection +/- Omentectomy in Gastric Cancer , Asian Journal of Research in Medicine and Medical Science: 2019 - Volume 1 [Issue 1]